Zealand Pharma Partners with Benchling to Advance R&D of Engineered Peptide Medicines

Fast-growing Danish biotech adopts Benchling R&D Cloud for greater data accessibility, collaboration, and compliance San Francisco, USA & Zurich, Switzerland. Today Benchling announced that Zealand Pharma A/S, (“Zealand”) a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data, [...]

Sapio Sciences Launches New Multimodal Registration Capabilities For Its Lab Informatics Platform

Sapio Sciences has enhanced its lab informatics platform with new multimodal entity registration capabilities for diverse product types, including small and large molecules and conjugates BALTIMORE, MD — Sapio Sciences, the science-awareTM lab informatics platform, today announced the launch of its new multimodal registration capabilities. This new functionality unifies small-molecule, large-molecule, and multimodal discovery workflows, [...]

ZEISS and Argolight announce partnership to enhance microscopy imaging quality control

Jena/Germany | ZEISS Research Microscopy Solutions Today, ZEISS and Argolight announced their strategic partnership. The collaboration aims to seamlessly integrate cutting-edge quality control solutions of the French company into the extensive line of ZEISS microscopes. This will enable users to accurately measure and assess the performance of their microscopy systems. An indispensable solution for comprehensive [...]

Profluent Successfully Edits Human Genome with OpenCRISPR-1, the World’s First AI-Created and Open-Source Gene Editor

OpenCRISPR-1 is publicly available and free to license for ethical research and commercial use BERKELEY, Calif.--Profluent, the AI-first protein design company, today debuted the OpenCRISPRTM initiative, releasing the world’s first open-source, AI-generated gene editor. With this launch, Profluent demonstrates the first successful precision editing of the human genome with customizable gene editors designed from scratch [...]

SanaGen, InSphero and Sanquin Awarded with Eurostars Grant for a Breakthrough Gene Therapy, Poised to Become First “Cure” for Severe Alpha-1 anti-Trypsin (AAT) Deficiency (AATD)

In a notable collaboration that underscores the power of innovation in drug discovery, SanaGen and InSphero, alongside the renowned Sanquin research institute, have been awarded a 1.3 million euro grant for the ambitious project NOCAAVAAT. Zürich -- In a notable collaboration that underscores the power of innovation in drug discovery, SanaGen and InSphero, alongside the renowned Sanquin research [...]

Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns

News Summary: New line of GTxResolve™ Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the development of cell & gene-based therapeutics. Reduces problematic non-specific binding, minimizes mobile phase method development challenges, and provides higher throughput separation efficiency. Increases resolution up to 50% for components present within mRNA, lipid nanoparticles (LNP), and viral [...]

Bruker to Acquire the NanoString Business in an Asset Deal

NanoString is an Established Leader and Valuable Innovator in Gene Expression Profiling and Spatial Transcriptomics for Scientific and Clinical Research in Healthcare BILLERICA, Mass. -- Bruker Corporation (Nasdaq: BRKR) today announced that it has entered into a definitive acquisition agreement with NanoString Technologies, Inc., headquartered in Seattle, Washington, a leading provider of solutions for spatial transcriptomics and [...]

eLabNext: The Digital Backbone of Colossal Biosciences’ Mammoth Revival Mission

BOSTON, MA — In the wake of widespread media attention surrounding Colossal Biosciences' ambitious de-extinction efforts, eLabNext, a pioneer in digital lab solutions, is proud to spotlight its instrumental role in supporting the groundbreaking research aimed at reviving the woolly mammoth. eLabNext's flagship software, eLabJournal has been a critical tool for the management of complex data and workflows associated with Colossal Biosciences’ historic [...]

MGI Tech opens Customer Experience Center in Brazil to contribute to the advancement of genomics in Latin America

The laboratory has state-of-the-art technology to support medical research of clinical labs and healthcare institutions, improving precision diagnoses and treatments.  The agricultural sector can also benefit. São Paulo, Brazil – Contributing to the advancement of genomics in Latin America, MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life [...]

Launch of high-quality mutant T7 RNA polymerase suitable for mRNA vaccine and therapeutic development

Takara Bio has released PrimeCap T7 RNA Polymerase (low dsRNA) (hereafter referred to as PrimeCap T7 RNA Polymerase), a mutant T7 RNA polymerase suitable for mRNA therapeutic research and development, in March 2024. mRNA vaccines have been deployed effectively as a defense against the coronavirus, with ongoing research extending beyond infectious disease prevention to encompass [...]

Access IBO on Knowledge Center